Jean Bismuth, MD
Vascular Surgery · Houston, TXNPI 1639330053
Payments from drug & device makers
Across 446 payments — averaging $855.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$143K
- Siemens Medical Solutions USA, Inc.$84K
- Penumbra, Inc.$83K
- Cook Incorporated$22K
- Philips North America LLC$19K
- GE HealthCare$14K
- plus $17K from 32 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 158 | $142,858 |
| Siemens Medical Solutions USA, Inc. | 3 | $83,860 |
| Penumbra, Inc. | 90 | $83,023 |
| Cook Incorporated | 7 | $22,290 |
| Philips North America LLC | 22 | $19,106 |
| GE HealthCare | 8 | $13,631 |
| Johnson & Johnson(3 entities) | 10 | $6,296 |
| Cook Medical LLC | 75 | $4,128 |
| Boston Scientific | 14 | $2,778 |
| Medtronic(2 entities) | 8 | $596 |
| Shockwave Medical, Inc | 4 | $352 |
| Silk Road Medical, Inc. | 8 | $292 |
| Avinger Inc. | 3 | $232 |
| Baxter Healthcare | 2 | $204 |
| Heartflow, Inc. | 2 | $184 |
| Wound Management Technologies, Inc | 3 | $178 |
| Surmodics, Inc. | 2 | $167 |
| Biom'up France SAS | 1 | $151 |
| Sanara Medtech Inc. | 4 | $148 |
| Kerecis Limited | 1 | $132 |
| Abbott | 1 | $120 |
| Livanova USA, Inc. | 1 | $119 |
| Merit Medical Systems Inc | 1 | $110 |
| Stryker | 1 | $95 |
| Angiodynamics, Inc. | 1 | $93 |
| Endologix LLC | 2 | $76 |
| Cvrx, Inc. | 2 | $74 |
| Tactile Systems Technology Inc | 2 | $73 |
| Artivion, Inc. | 1 | $58 |
| Medical Device Business Services, Inc. | 1 | $54 |
| Bolton Medical Inc | 1 | $30 |
| Bard Peripheral Vascular, Inc. | 1 | $26 |
| Elutia, Inc. | 1 | $21 |
| Aroa Biosurgery Incorporated | 1 | $19 |
| Organogenesis Inc. | 1 | $18 |
| CSL Behring | 1 | $16 |
| Amgen | 1 | $15 |
| Pfizer | 1 | $15 |
How this compares
$381,637 in reported general payments places this provider in the 95th percentile of 347 vascular surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular surgery in Houston
- Alan LumsdenHouston$2.4M
- Gustavo OderichHouston$999K
- Samuel LeonardHouston$431K
- Ali AzizzadehHouston$387K
- Kristofer Charlton-OuwHouston$240K
- Maham RahimiHouston$221K
- Jayer ChungHouston$179K
- Steven MaximusHouston$140K
- Charudatta BavareHouston$130K
- Joseph MillsHouston$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.